GQG Partners’s Insulet PODD Stock Holding History

GQG Partners’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-719	Closed	-$204K	–	101
2021 Q3	$204K	Buy	+719	New	+$205K	﹤0.01%	84
2021 Q1	–	Sell	-1,240	Closed	-$317K	–	78
2020 Q4	$317K	Hold	1,240	–	–	﹤0.01%	54
2020 Q3	$293K	Hold	1,240	–	–	﹤0.01%	65
2020 Q2	$241K	Hold	1,240	–	–	﹤0.01%	62
2020 Q1	$205K	Hold	1,240	–	–	﹤0.01%	57
2019 Q4	$212K	Buy	+1,240	New	+$207K	﹤0.01%	56

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

GQG Partners's PODD Position: Q4 2021 in Review

GQG Partners sold out of Insulet (PODD) in Q4 2021, closing a stake of 719 shares — an estimated $204K sold.

GQG Partners first reported a position in PODD in Q4 2019 and held it in 6 quarters. The position peaked at $317K in Q4 2020. 475 funds tracked by Wall St. Rank hold PODD as of Q4 2021.

GQG Partners reported no remaining Insulet position as of Q4 2021 after selling out during the quarter.
GQG Partners sold 719 Insulet shares in Q4 2021, an estimated $204K.
GQG Partners first reported a position in Insulet in Q4 2019 and held it in 6 quarters.
GQG Partners's Insulet position peaked at $317K in Q4 2020.
475 funds tracked by Wall St. Rank held Insulet as of Q4 2021.

Based on GQG Partners's 13F filing for Q4 2021, filed 14 Feb 2022.